193 related articles for article (PubMed ID: 2787611)
1. Anti-neutrophil-elastase defenses of the lower respiratory tract in alpha 1-antitrypsin deficiency directly augmented with an aerosol of alpha 1-antitrypsin.
Hubbard RC; Brantly ML; Sellers SE; Mitchell ME; Crystal RG
Ann Intern Med; 1989 Aug; 111(3):206-12. PubMed ID: 2787611
[TBL] [Abstract][Full Text] [Related]
2. Recombinant DNA-produced alpha 1-antitrypsin administered by aerosol augments lower respiratory tract antineutrophil elastase defenses in individuals with alpha 1-antitrypsin deficiency.
Hubbard RC; McElvaney NG; Sellers SE; Healy JT; Czerski DB; Crystal RG
J Clin Invest; 1989 Oct; 84(4):1349-54. PubMed ID: 2794066
[TBL] [Abstract][Full Text] [Related]
3. Strategies for aerosol therapy of alpha 1-antitrypsin deficiency by the aerosol route.
Hubbard RC; Crystal RG
Lung; 1990; 168 Suppl():565-78. PubMed ID: 2117165
[TBL] [Abstract][Full Text] [Related]
4. Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema.
Wewers MD; Casolaro MA; Sellers SE; Swayze SC; McPhaul KM; Wittes JT; Crystal RG
N Engl J Med; 1987 Apr; 316(17):1055-62. PubMed ID: 3494198
[TBL] [Abstract][Full Text] [Related]
5. Fate of aerosolized recombinant DNA-produced alpha 1-antitrypsin: use of the epithelial surface of the lower respiratory tract to administer proteins of therapeutic importance.
Hubbard RC; Casolaro MA; Mitchell M; Sellers SE; Arabia F; Matthay MA; Crystal RG
Proc Natl Acad Sci U S A; 1989 Jan; 86(2):680-4. PubMed ID: 2783491
[TBL] [Abstract][Full Text] [Related]
6. Alpha-1-antitrypsin augmentation therapy for alpha-1-antitrypsin deficiency.
Hubbard RC; Crystal RG
Am J Med; 1988 Jun; 84(6A):52-62. PubMed ID: 3289387
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the S-type of alpha-1-antitrypsin as an in vivo and in vitro inhibitor of neutrophil elastase.
Ogushi F; Hubbard RC; Fells GA; Casolaro MA; Curiel DT; Brantly ML; Crystal RG
Am Rev Respir Dis; 1988 Feb; 137(2):364-70. PubMed ID: 3257660
[TBL] [Abstract][Full Text] [Related]
8. Pulmonary deposition and clearance of aerosolized alpha-1-proteinase inhibitor administered to dogs and to sheep.
Smith RM; Traber LD; Traber DL; Spragg RG
J Clin Invest; 1989 Oct; 84(4):1145-54. PubMed ID: 2794051
[TBL] [Abstract][Full Text] [Related]
9. Z-type alpha 1-antitrypsin is less competent than M1-type alpha 1-antitrypsin as an inhibitor of neutrophil elastase.
Ogushi F; Fells GA; Hubbard RC; Straus SD; Crystal RG
J Clin Invest; 1987 Nov; 80(5):1366-74. PubMed ID: 3500183
[TBL] [Abstract][Full Text] [Related]
10. Biochemical efficacy and safety of monthly augmentation therapy for alpha 1-antitrypsin deficiency.
Hubbard RC; Sellers S; Czerski D; Stephens L; Crystal RG
JAMA; 1988 Sep; 260(9):1259-64. PubMed ID: 3261353
[TBL] [Abstract][Full Text] [Related]
11. Aerosol alpha 1-antitrypsin treatment for cystic fibrosis.
McElvaney NG; Hubbard RC; Birrer P; Chernick MS; Caplan DB; Frank MM; Crystal RG
Lancet; 1991 Feb; 337(8738):392-4. PubMed ID: 1671425
[TBL] [Abstract][Full Text] [Related]
12. Comparison of alpha-1-antitrypsin levels and antineutrophil elastase capacity of blood and lung in a patient with the alpha-1-antitrypsin phenotype null-null before and during alpha-1-antitrypsin augmentation therapy.
Wewers MD; Casolaro MA; Crystal RG
Am Rev Respir Dis; 1987 Mar; 135(3):539-43. PubMed ID: 3493719
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for emphysema. Cigarette smoking is associated with a reduction in the association rate constant of lung alpha 1-antitrypsin for neutrophil elastase.
Ogushi F; Hubbard RC; Vogelmeier C; Fells GA; Crystal RG
J Clin Invest; 1991 Mar; 87(3):1060-5. PubMed ID: 1999486
[TBL] [Abstract][Full Text] [Related]
14. Augmentation therapy of alpha 1-antitrypsin deficiency.
Hubbard RC; Crystal RG
Eur Respir J Suppl; 1990 Mar; 9():44s-52s. PubMed ID: 2340051
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil accumulation in the lung in alpha 1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages.
Hubbard RC; Fells G; Gadek J; Pacholok S; Humes J; Crystal RG
J Clin Invest; 1991 Sep; 88(3):891-7. PubMed ID: 1653278
[TBL] [Abstract][Full Text] [Related]
16. Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema.
Gadek JE; Fells GA; Zimmerman RL; Rennard SI; Crystal RG
J Clin Invest; 1981 Oct; 68(4):889-98. PubMed ID: 6169740
[TBL] [Abstract][Full Text] [Related]
17. Aerosolization of recombinant SLPI to augment antineutrophil elastase protection of pulmonary epithelium.
Vogelmeier C; Buhl R; Hoyt RF; Wilson E; Fells GA; Hubbard RC; Schnebli HP; Thompson RC; Crystal RG
J Appl Physiol (1985); 1990 Nov; 69(5):1843-8. PubMed ID: 2272977
[TBL] [Abstract][Full Text] [Related]
18. Oxidants spontaneously released by alveolar macrophages of cigarette smokers can inactivate the active site of alpha 1-antitrypsin, rendering it ineffective as an inhibitor of neutrophil elastase.
Hubbard RC; Ogushi F; Fells GA; Cantin AM; Jallat S; Courtney M; Crystal RG
J Clin Invest; 1987 Nov; 80(5):1289-95. PubMed ID: 2824559
[TBL] [Abstract][Full Text] [Related]
19. Alpha-1-antitrypsin PLowell: a normally functioning variant present in low concentration.
Cook L; Burdon J; Brenton S; Janus ED; Knight K
Aust N Z J Med; 1995 Dec; 25(6):695-7. PubMed ID: 8770333
[TBL] [Abstract][Full Text] [Related]
20. The pallid mouse. A model of genetic alpha 1-antitrypsin deficiency.
Martorana PA; Brand T; Gardi C; van Even P; de Santi MM; Calzoni P; Marcolongo P; Lungarella G
Lab Invest; 1993 Feb; 68(2):233-41. PubMed ID: 8441253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
